CELG - The Biotech M&A Landscape
"A cynic is a man who, when he smells flowers, looks around for a coffin." - H.L. Mencken
Stocks ended January on a high note with the major indices up just under one and half percent last week. It was the best start to a New Year since 1987 for investors after a dismal fourth quarter.
The biotech sector has been a strong performer so far in 2019. This area was boosted nicely by the big acquisitions of Celgene (CELG) and Loxo Oncology (LOXO) to kick off the New Year. While